DEQUADIN

This brand name is authorized in Nigeria. It is also authorized in Canada, Hong Kong SAR China.

Active ingredients

The drug DEQUADIN contains one active pharmaceutical ingredient (API):

1	Dequalinium UNII XYS8INN1I6 - DEQUALINIUM CHLORIDE
	Dequalinum is an anti-infective and antiseptic agent belonging to the class of quaternary ammonium compounds. The primary mechanism of action is an increase in bacterial cell permeability and the subsequent loss of enzyme activity, finally resulting in cell death.
	Read more about Dequalinium

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-0393	Lozenge	DEQUADIN LOZENGES LOZENGE 250 mg 250sachet1pack	47 RNW-PP-126857 DEQUADIN LOZENGES DEQUALINIUM CHLORIDE Dequalinium chloride 250mcg 04-0393 Drugs RESPIRATORY SYSTEM Nigerian Products 250sachet1pack Over The Counter (OTC) 4/23/2020 EVANS BAROQUE LIMITED, LAGOS BADAGRY EXPRESS WAY, AGBARA INDUSTRIAL ESTATE, AGBARA, OGUN STATE ISOLO LAGOS 8033304149 regulatory@evansbaroque.com EVANS MEDICALPLC, KM. 32, LAGOS-BADAGRY EXPRESSWAY, AGBARA INDUSTRIAL ESTATE, AGBARA, OGUN STATE, Nigeria	06/07/2023

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DEQUADIN Lozenges	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R02AA02	Dequalinium	R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics
Discover more medicines within R02AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02091453, 02100207
HK	Department of Health Drug Office	25439, 25463, 58470
NG	Registered Drug Product Database	04-0393